99 related articles for article (PubMed ID: 28817295)
1. Does the offer of free prescriptions increase generic prescribing?
Stuart B; Hendrick F; Dougherty JS; Xu J
Am J Manag Care; 2017 Jun; 23(6):e193-e201. PubMed ID: 28817295
[TBL] [Abstract][Full Text] [Related]
2. Impact of formulary restrictions on medication use and costs.
Shen X; Stuart BC; Powers CA; Tom SE; Magder LS; Perfetto EM
Am J Manag Care; 2017 Aug; 23(8):e265-e274. PubMed ID: 29087150
[TBL] [Abstract][Full Text] [Related]
3. In Medicare Part D plans, low or zero copays and other features to encourage the use of generic statins work, could save billions.
Hoadley JF; Merrell K; Hargrave E; Summer L
Health Aff (Millwood); 2012 Oct; 31(10):2266-75. PubMed ID: 23048108
[TBL] [Abstract][Full Text] [Related]
4. How Low-Income Subsidy Recipients Respond to Medicare Part D Cost Sharing.
Stuart B; Hendrick FB; Xu J; Dougherty JS
Health Serv Res; 2017 Jun; 52(3):1185-1206. PubMed ID: 27324201
[TBL] [Abstract][Full Text] [Related]
5. Encouraging generic use can yield significant savings.
Zimmerman C
Find Brief; 2012 Nov; 15(8):1-3. PubMed ID: 23213854
[TBL] [Abstract][Full Text] [Related]
6. Impact of medicare part D plan features on use of generic drugs.
Tang Y; Gellad WF; Men A; Donohue JM
Med Care; 2014 Jun; 52(6):541-8. PubMed ID: 24824538
[TBL] [Abstract][Full Text] [Related]
7. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
Goedken AM; Urmie JM; Farris KB; Doucette WR
Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
[TBL] [Abstract][Full Text] [Related]
8. Potential savings associated with drug substitution in Medicare Part D: the Translating Research into Action for Diabetes (TRIAD) study.
Duru OK; Ettner SL; Turk N; Mangione CM; Brown AF; Fu J; Simien L; Tseng CW
J Gen Intern Med; 2014 Jan; 29(1):230-6. PubMed ID: 23975059
[TBL] [Abstract][Full Text] [Related]
9. The Effects of Cost Sharing on Adherence to Medications Prescribed for Concurrent Use: Do Definitions Matter?
Sacks NC; Burgess JF; Cabral HJ; McDonnell ME; Pizer SD
J Manag Care Spec Pharm; 2015 Aug; 21(8):678-87. PubMed ID: 26233540
[TBL] [Abstract][Full Text] [Related]
10. Impact of Cost Sharing on Therapeutic Substitution: The Story of Statins in 2006.
Li P; Schwartz JS; Doshi JA
J Am Heart Assoc; 2016 Nov; 5(11):. PubMed ID: 27836822
[TBL] [Abstract][Full Text] [Related]
11. Impact of formulary restrictions on medication intensification in diabetes treatment.
Stuart BC; Slejko JF; Rueda JD; Cooke CE; Shen X; Roberto P; Ciarametaro M; Dubois R
Am J Manag Care; 2018 May; 24(5):239-246. PubMed ID: 29851442
[TBL] [Abstract][Full Text] [Related]
12. Association of Industry Payments to Physicians With the Prescribing of Brand-name Statins in Massachusetts.
Yeh JS; Franklin JM; Avorn J; Landon J; Kesselheim AS
JAMA Intern Med; 2016 Jun; 176(6):763-8. PubMed ID: 27159336
[TBL] [Abstract][Full Text] [Related]
13. Trends in Medicare Part D coverage of generics with equivalent brand-name drugs.
Dusetzina SB; Cubanski J; Roberts AW; Hoadley J; True S; Nshuti L; Neuman T
Am J Manag Care; 2021 Jul; 27(7):283-288. PubMed ID: 34314117
[TBL] [Abstract][Full Text] [Related]
14. Zero copayment for generic statins could save billions.
Manag Care; 2013 Mar; 22(3):44. PubMed ID: 23610806
[No Abstract] [Full Text] [Related]
15. Association of Medicare Part D medication out-of-pocket costs with utilization of statin medications.
Karaca-Mandic P; Swenson T; Abraham JM; Kane RL
Health Serv Res; 2013 Aug; 48(4):1311-33. PubMed ID: 23278369
[TBL] [Abstract][Full Text] [Related]
16. Patient adherence to generic versus brand statin therapy after acute myocardial infarction: Insights from the Can Rapid Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the American College of Cardiology/American Heart Association Guidelines Registry.
O'Brien EC; McCoy LA; Thomas L; Peterson ED; Wang TY
Am Heart J; 2015 Jul; 170(1):55-61. PubMed ID: 26093864
[TBL] [Abstract][Full Text] [Related]
17. Brand-name prescription drug use among Veterans Affairs and Medicare Part D patients with diabetes: a national cohort comparison.
Gellad WF; Donohue JM; Zhao X; Mor MK; Thorpe CT; Smith J; Good CB; Fine MJ; Morden NE
Ann Intern Med; 2013 Jul; 159(2):105-14. PubMed ID: 23752663
[TBL] [Abstract][Full Text] [Related]
18. Evolutions in both co-payment and generic market share for common medication in the Belgian reference pricing system.
Fraeyman J; Verbelen M; Hens N; Van Hal G; De Loof H; Beutels P
Appl Health Econ Health Policy; 2013 Oct; 11(5):543-52. PubMed ID: 24062144
[TBL] [Abstract][Full Text] [Related]
19. Impact of final short-fill rule on Medicare Part D costs and long-term care pharmacy dispensing.
Bazalo G; Weiss RC
Consult Pharm; 2012 Apr; 27(4):269-73. PubMed ID: 22498986
[TBL] [Abstract][Full Text] [Related]
20. Secular Trends in the Cost of Immunosuppressants after Solid Organ Transplantation in the United States.
Helmuth ME; Liu Q; Turenne MN; Park JM; Oguntimein M; Dutcher SK; Balkrishnan R; Sharma P; Zee J; Leichtman AB; Smith AR
Clin J Am Soc Nephrol; 2019 Mar; 14(3):421-430. PubMed ID: 30819667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]